NEXI
Neximmune Inc

1,706
Loading...
Loading...
NexImmune, Inc. is a clinical stage biotechnology company, which engages in the development of novel approach to immunotherapy designed to employ the body's own T cells to generate an antigen-specific cell-mediated immune response with curative potential for the patient. Its product candidates are NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM. The company was founded by Kenneth C. Carter, Jonathan Schneck, and Mathias Oelke on June 7, 2011 and is headquartered in Gaithersburg, MD.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Neximmune Inc?
What is the 52-week high for Neximmune Inc?
What is the 52-week low for Neximmune Inc?
What is Neximmune Inc stock price today?
What was Neximmune Inc stock price yesterday?
What is the 50-day moving average of Neximmune Inc?

Latest NEXI News

View

Advertisement|Remove ads.

Advertisement|Remove ads.